1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40

Details for Australian Patent Application No. 2009221087 (hide)

Owner Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.

Inventors Furlotti, Guido; Cazzolla, Nicola; Guglielmotti, Angelo; Mangano, Giorgina

Agent Griffith Hack

Pub. Number AU-A-2009221087

PCT Pub. Number WO2009/109616

Priority 08425140.4 07.03.08 EP

Filing date 5 March 2009

Wipo publication date 11 September 2009

International Classifications

C07D 231/54 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/109616 Priority application(s): WO2009/109616

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221089-1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1

2009221085-Novel crustacean androgenic gland hormone